Background: ANX was born from a shell of Biokeys. Biokeys was a Scandinavian researched get rich quick hopeful dream of CoFactor being the replacement and improvement over Leucovorin F-5U via some initial experimentation at California State Universities.

If Icahn had invested on the ground floor, he would have bought ANX for .05 to .07 cents a share, like Levine and crew.

To make a long story short, Icahn got in at just under $2 per share. He bought into the hype. He got carried away with the story.

Please don't tell me Icahn bought after CoFactor's demise. It's simply not true.

Icahn made a mistake and bought with the hope CoFactor was an innovative vitamin B turbocharger to Leucovorin, even though it was just a derivative thereof, Leucovorin already being full of folic acid constituent compounds.

Fourth grade Singapore Math and some basic 9th grade Chemistry could have taught him what the meaning of a derivative is in this case (vit B folic acid properites from Leucovorin).

Good luck to all involved. Truth. HA! HA! HA!